SynthesisCancer medicine2022

Salvage nivolumab and ipilimumab after prior anti-PD-1/PD-L1 therapy in metastatic renal cell carcinoma: A meta-analysis.

Yuanquan Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.